Widespread intronic polyadenylation diversifies immune cell transcriptomes.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 29712909.
- Also identified by DOI 10.1038/s41467-018-04112-z and PMC identifier 5928244.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Alternative cleavage and polyadenylation (ApA) is known to alter untranslated region (3'UTR) length but can also recognize intronic polyadenylation (IpA) signals to generate transcripts that lose part or all of the coding region. We analyzed 46 3'-seq and RNA-seq profiles from normal human tissues, primary immune cells, and multiple myeloma (MM) samples and created an atlas of 4927 high-confidence IpA events represented in these cell types. IpA isoforms are widely expressed in immune cells, differentially used during B-cell development or in different cellular environments, and can generate truncated proteins lacking C-terminal functional domains. This can mimic ectodomain shedding through loss of transmembrane domains or alter the binding specificity of proteins with DNA-binding or protein-protein interaction domains. MM cells display a striking loss of IpA isoforms expressed in plasma cells, associated with shorter progression-free survival and impacting key genes in MM biology and response to lenalidomide.
Medical subject headings
- Heavy Chain Disease
- Immunoglobulin mu-Chains
- Introns
- Multiple Myeloma
- Plasma Cells
- Polyadenylation
- Transcriptome